<DOC>
	<DOCNO>NCT00235625</DOCNO>
	<brief_summary>Turmeric ( Curcuma Longa ) member ginger family best know culinary use major component curry powder . The volatile oil ( call curcuminoids ) turmeric root , however , anti-inflammatory action make promising candidate treatment psoriasis . For example , curcumin show improve psoriasis experiment use vitro model . Turmeric show minimal side effect dose 12 gram per day . The purpose study determine safety estimate efficacy oral Curcuminoid C3 Complex® patient chronic psoriasis vulgaris .</brief_summary>
	<brief_title>Curcuminoids Treatment Chronic Psoriasis Vulgaris</brief_title>
	<detailed_description>This study longer recruit .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Subjects must chronic plaque type psoriasis , investigator 's opinion clinically stable require urgent treatment standard , FDA approve psoriasis therapy . Psoriasis must cover least 6 % subject 's body surface area lesion must moderate plaque thickness Subjects must willing capacity give write informed consent Ages 18 75 Subjects must available total duration study ( 16 week ) Female subject sexually active male partner must postmenopausal , surgically incapable childbearing , use medically acceptable method contraception throughout entire study period . Medically acceptable method contraception may use subject and/or partner include oral contraceptive patch , diaphragms spermicide , IUD , condom spermicide , progestin implant injection . Females take oral contraceptive must take consistently least two month prior receive study medication . All female subject must consent urine pregnancy test screen start study , must negative time point . Male subject sexually active female partner capable fertilization must ensure female partner either postmenopausal , surgically incapable childbearing , use medically acceptable method contraception throughout entire study period •Females subject pregnant nursing child •Subjects sensitive allergic turmeric curry powder •History alcohol drug abuse within 12 month screen visit •Subjects rapidly improve deteriorate psoriasis follow variable type psoriasis : guttate , erythrodermic , pustular psoriasis •Use systemic treatment psoriasis ( include methotrexate , cyclosporine , alefacept , adalimumab , efalizumab , infliximab , etanercept , etretinate , systemic steroid PUVA ) within 3 month prior day 0 time study . •Use topical treatment UVB therapy psoriasis ( include nonmedicated emollient shampoo ) within 14 day prior day 0 time study period . •Subjects , receive experimental drug , use experimental medical devise within 30 day prior screen •Clinically significant laboratory abnormality •Subjects significant medical comorbidities •Subjects dose follow medication change within 1 month day 0 : clonidine , digoxin , betablockers , lithium , antimalarial •Subjects unable swallow pill •Subject unable adhere protocol reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Alternative Medicine</keyword>
	<keyword>Psoriasis</keyword>
	<keyword>Turmeric</keyword>
	<keyword>Curcumin</keyword>
	<keyword>Dermatology</keyword>
</DOC>